-
1 Comment
Shanghai Shyndec Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 1.4% below its 200 day moving average.
From a valuation standpoint, the stock is 90.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.9.
Shanghai Shyndec Pharmaceutical Co., Ltd's total revenue rose by 0.6% to $3B since the same quarter in the previous year.
Its net income has dropped by 78.0% to $18M since the same quarter in the previous year.
Finally, its free cash flow grew by 123.0% to $190M since the same quarter in the previous year.
Based on the above factors, Shanghai Shyndec Pharmaceutical Co., Ltd gets an overall score of 3/5.
| Sector | Healthcare |
|---|---|
| Industry | Drug Manufacturers - Specialty & Generic |
| Exchange | SHG |
| CurrencyCode | CNY |
| ISIN | CNE000001JG2 |
| Target Price | 17.13 |
|---|---|
| Market Cap | 14B |
| PE Ratio | 12.61 |
| Beta | 0.33 |
| Dividend Yield | None |
Shanghai Shyndec Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. The company offers 6-APA, 7-ADCA, 7-ACA, D-7ACA, and penicillin industrial potassium; pharmaceutical intermediates, anti-infective pharmaceutical intermediates salt, and ceftriaxone sodium crude salt; and amoxicillin, clavulanic acid series, azithromycin, and ceftriaxone sodium. It also provides anti-infective pharmaceutical raw materials; urogenital system pharmaceutical raw materials, systemic anti-infective drugs; cardiovascular system medications; urogenital system medications and hormones; drugs for the nervous system; diclofenac sodium sustained-release tablets for musculoskeletal system; digestive tract and metabolism medications; anti-tumor and immunomodulatory agent; blood and hematopoietic system medications; respiratory system medications; animal vaccines; and general health products. Shanghai Shyndec Pharmaceutical Co., Ltd. was founded in 2000 and is based in Shanghai, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 600420.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
